MTLC Polyclonal Antibody, PE-Cy7 Conjugated
Product Specifications
Background
May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity) .
Synonyms
MTLC; Myc target protein 1; Myc target in myeloid cells protein 1; MYCT1; MTMC1
Gene ID
80177
Swiss Prot
Q8N699
Cellular Locus
Nucleus
Host
Rabbit
Cross Reactivity
Human, Mouse
Immunogen
21-100/235
Target
MTLC
Clonality
Polyclonal
Isotype
IgG
Conjugation
PE-Cy7
Source
KLH conjugated synthetic peptide derived from human MTLC
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/780nm
Concentration
1µg/µl
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
80177
Predicted Cross Reactivity
Rat, Dog
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7032323-01 0.02 mg
Recombinant Dictyostelium discoideum Probable tetraspanin tspB (tspB)
Sign In for Pricing
View Details MBS7032323-02 0.1 mg
Recombinant Dictyostelium discoideum Probable tetraspanin tspB (tspB)
Sign In for Pricing
View Details 
MBS7032323-03 5x 0.1 mg
Recombinant Dictyostelium discoideum Probable tetraspanin tspB (tspB)
Sign In for Pricing
View Details 